IMM 6.90% 27.0¢ immutep limited

market depth gap reduced today, page-45

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343
    ""anyway, i suspect there will not be a reply to kbears post, basically because there is probably no more lies you can put forward."'

    It's ok ymav4294 you have already called me a lier in the past. For your sake we will assume the FDA approved a Phase3 trial before we received any results from the current Phase2b ( including interium results) Amazing ...must be the first time in history running a Phase3 trial before phase2 results are out.

    Maybe you could explain what happened to the expected recruitment rates for you Phase 3 trial ..... below expectations?...waiting for confirmatory Phase2 data maybe?.......or just taking a punt and running a Phase3 for the hell of it with a whole 50 patients recruited in 18 months.

    Goodluck mate.

    ""Based on expected recruitment rates, full patient enrolment should be complete by around Q3-Q4 2013. CANVAS is an event driven study and actual study timelines will be dependent on patient outcomes in the trial (i.e. how long patients stay in remission and stay alive). As such, any timelines provided are indicative only and are provided only as a guideline.""
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.020(6.90%)
Mkt cap ! $392.7M
Open High Low Value Volume
29.0¢ 29.0¢ 27.0¢ $569.8K 2.076M

Buyers (Bids)

No. Vol. Price($)
8 706076 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 100000 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.